Invesco S&P 500 Equal Weight Health Care ETF
RSPH
89 hedge funds and large institutions have $334M invested in Invesco S&P 500 Equal Weight Health Care ETF in 2015 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 33 increasing their positions, 18 reducing their positions, and 4 closing their positions.
475% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 4
83% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 18
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
26% more capital invested
Capital invested by funds: $266M → $334M (+$68.1M)
25% more funds holding
Funds holding: 71 → 89 (+18)
19.8% more ownership
Funds ownership: 402.92% → 422.72% (+20%)
Top Buyers
Top Sellers
RSPH Hedge Fund Activity: Q2 2015 in Review
89 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Invesco S&P 500 Equal Weight Health Care ETF (RSPH) for Q2 2015, worth a combined $334M — up 26% from $266M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new RSPH positions and 4 closed out — a net gain of 19 holders — while 33 added to existing stakes and 18 trimmed.
The largest buyer was Wilbanks Smith & Thomas Asset Management, adding an estimated $10.4M. The largest seller was Raymond James & Associates, cutting an estimated $4.72M.
- 89 institutional investors held Invesco S&P 500 Equal Weight Health Care ETF (RSPH) as of Q2 2015, up from 71 in Q1 2015.
- Funds reported $334M of Invesco S&P 500 Equal Weight Health Care ETF stock for Q2 2015, up 26% quarter-over-quarter.
- 23 funds opened new Invesco S&P 500 Equal Weight Health Care ETF positions in Q2 2015 and 4 closed out, a net change of +19 holders.
- The largest Invesco S&P 500 Equal Weight Health Care ETF buyer in Q2 2015 was Wilbanks Smith & Thomas Asset Management, an estimated $10.4M added.
- The largest Invesco S&P 500 Equal Weight Health Care ETF seller in Q2 2015 was Raymond James & Associates, an estimated $4.72M sold.
Based on aggregated 13F filings for Q2 2015.